BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25823425)

  • 21. The use of streptokinase for restoration of patency to hemodialysis central venous catheters: a low-cost, safe and effective option.
    Bashardoust B; Habibzadeh S; Sharghi A; Eskandari R; Maleki N
    J Vasc Access; 2017 Sep; 18(5):e70. PubMed ID: 28777422
    [No Abstract]   [Full Text] [Related]  

  • 22. Restoring patency of occluded central venous catheters.
    Hurtubise MR; Bottino JC; Lawson M; McCredie KB
    Arch Surg; 1980 Feb; 115(2):212-3. PubMed ID: 7356837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
    Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
    Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term continuous infusion thrombolytic therapy for occluded central nervous venous dialysis catheters.
    Peska DN; DeLange B; Gratch JO; Bleicher JN; Pertusi RM; Mueller D
    Am J Manag Care; 1997 Feb; 3(2):261-4. PubMed ID: 10169260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for Occluded Central Venous Catheters: A Meta-analysis.
    da Costa ACC; Vieira NNP; Vasques CI; Ferreira EB; Guerra ENS; Dos Reis PED
    Pediatrics; 2019 Dec; 144(6):. PubMed ID: 31757859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of rt-PA infusion in tunnelled dialysis catheters.
    Davies J; Casey J; Li C; Crowe AV; McClelland P
    EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing peripherally inserted central catheter-related venous thrombosis: How I do it.
    Chaitowitz I; Heng R; Bell K
    Australas Radiol; 2006 Apr; 50(2):132-5. PubMed ID: 16635031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
    Eyrich H; Walton T; Macon EJ; Howe A
    Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin-nonspecific agents in the direct thrombolytic treatment of venous sinus thrombosis.
    Yang YH; Liu CK; Shih MC; Chou MS
    QJM; 2002 Nov; 95(11):763-4. PubMed ID: 12391390
    [No Abstract]   [Full Text] [Related]  

  • 30. Tackling the Achilles' heel of hemodialysis.
    Winkelmayer WC
    N Engl J Med; 2011 Jan; 364(4):372-4. PubMed ID: 21268730
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy, safety, and cost of thrombolytic agents for the management of dysfunctional hemodialysis catheters: a systematic review.
    Hilleman D; Campbell J
    Pharmacotherapy; 2011 Oct; 31(10):1031-40. PubMed ID: 21950645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to manage catheter-related right atrial thrombosis: Our conservative approach.
    Rossi L; Covella B; Libutti P; Teutonico A; Casucci F; Lomonte C
    J Vasc Access; 2021 May; 22(3):480-484. PubMed ID: 32410490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.
    Atkinson JB; Bagnall HA; Gomperts E
    JPEN J Parenter Enteral Nutr; 1990; 14(3):310-1. PubMed ID: 2112648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior vena cava syndrome with central venous catheter for chemotherapy treated successfully with fibrinolysis.
    Guijarro Escribano JF; Antón RF; Colmenarejo Rubio A; Sáenz Cascos L; Sainz González F; Alguacil Rodríguez R
    Clin Transl Oncol; 2007 Mar; 9(3):198-200. PubMed ID: 17403633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteplase for the treatment of catheter occlusion in pediatric patients.
    Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
    Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
    Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
    J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower extremity deep venous thrombolysis: a new approach to obtaining access.
    Cragg AH
    J Vasc Interv Radiol; 1996; 7(2):283-8. PubMed ID: 9007812
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic therapy for femoral artery thrombosis after left cardiac catheterization in children.
    Liu Q; Yan CW; Zhao SH; Jiang SL; Xu ZY; Huang LJ; Ling J; Zheng H; Wang Y
    Chin Med J (Engl); 2009 Apr; 122(8):931-4. PubMed ID: 19493417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center.
    Hyman G; England M; Kibede S; Lee P; Willets G
    Nephron Clin Pract; 2004; 96(2):c39-42. PubMed ID: 14988596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
    Theiss W
    Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.